Management Team

Federico A. Tripodi - Chief Executive Officer

Federico A. Tripodi – Chief Executive Officer

Federico A. Tripodi was appointed CEO of Calyxt in May 2016. He holds a Master of Business Administration degree from Washington University’s Olin Business School, as well as an agronomic engineering degree from Buenos Aires University, and has gathered extensive experience in agricultural R&D and product development during his nearly two-decade career in the ag biotech and seeds industry. Prior to joining Calyxt, he worked as General Manager for Monsanto Company’s Sugarcane Division in Brazil for three years. He held other roles for Monsanto in Saint Louis, Mo., spanning Corporate Strategy (2011-2013), Omega-3 Program Lead (2009-2011), Oilseeds Global Quality Management Lead (2008-2009) and multiple other roles that involved managing multidisciplinary research teams in the technology organization between 2001 and 2008. During his tenure at Monsanto, Mr. Tripodi led or participated with early discovery and late commercialization phase product launches across the Americas, which included biotech consumer traits (improved composition soybean oils) and farmer traits (high yield, drought tolerance, insect protection and herbicide tolerance). Mr. Tripodi started his career in Argentina in 1998 in field research of biotechnology traits and chemistry formulations until he moved to Saint Louis in 2001. Mr. Tripodi also has experience as a director of a startup and serves on the board of directors for a not-for profit.

Dan Voytas - Chief Science Officer

Dan Voytas – Chief Science Officer

Dan graduated summa cum laude from Harvard College in 1984 and received his Ph.D. in genetics from Harvard Medical School in 1990. He is a co-founder of Calyxt and one of the inventors of the TALEN® technology. He continues to optimize the use of TALEN® for the targeted modification of plant genomes. In addition to his role at Calyxt, Voytas is a professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota (UMN), which he joined in 2008, and Director of the UMN’s Center for Genome Engineering. In 1992, Voytas joined the faculty at Iowa State University. Prior to this, he conducted postdoctoral research at Johns Hopkins University School of Medicine. Dan is an elected Fellow of the American Association for the Advancement of Science.

Feng Zhang - Chief Operations Officer

Feng Zhang – Chief Operations Officer

Feng obtained his Ph.D. from Iowa State University working on maize genetics and received post-doctoral training at the University of Georgia with Dr. Sue Wessler. Feng has more than 10 years of experience in plant biotechnology development and commercialization and has pioneered development of highly efficient technologies for crop improvement. He has published more than 20 peer-reviewed papers in high impact journals including Nature, Nature Methods, Proceedings of the National Academy of Sciences and Plant Cell. Feng is the co-inventor of more than 10 patents and patent applications. Before joining in Calyxt, he co-invented TALEN® technology with Dr. Dan Voytas at the University of Minnesota and Dr. Adam Bogdanove at Iowa State University. Feng joined Calyxt in 2010 to develop and lead the trait development programs for crops and vegetables.

Bryan W. J. Corkal – Chief Financial Officer

Bryan W. J. Corkal – Chief Financial Officer

Bryan joined Calyxt in December 2016 as Chief Financial Officer, and manages the company’s day-to-day financial operations. Bryan received his MBA from York University in Toronto, Canada and a B.Sc. in Civil Engineering from the University of Manitoba. Bryan is a CFA charter holder and is a CPA in the state of Missouri. Bryan brings extensive finance and commercial experience in the seeds and traits agricultural sector having worked over 17 years at Monsanto in a variety of finance and strategy roles including the acquisition and integration of several companies.
Prior to joining Calyxt, Bryan was the North America Supply Chain Finance Lead at Monsanto, a business with a total annual product cost of over $2B. Bryan’s career at Monsanto also included roles as Director of Investor Relations and Director of Finance (regional CFO) for the Latin America North division, a region covering 30 countries throughout the Americas, where he managed the controllership, credit & collections, tax, payroll, treasury, pension plan and FP&A functions. Early in his career, Bryan worked for Ernst & Young and Delcan Corporation as a consultant on a number of projects throughout Canada and Latin America.

Manoj Sahoo - Chief Commercial Officer

Manoj Sahoo – Chief Commercial Officer

Manoj Sahoo joined Calyxt as Chief Commercial Officer in March 2017. He holds a MBA from the Tuck School of Business at Dartmouth and Bachelor’s degree in Chemical Engineering from the National Institute of Technology in India. Manoj has more than two decades of experience working in a variety of roles covering commercial, strategy, business development and M&A for global corporations in ag, food, energy and materials fields.
Prior to joining Calyxt, Manoj was Assistant Vice President for Food Ingredients and Bio-industrial Enterprise at Cargill. At Cargill, he was responsible for revenues over $1 billion, leading the commercial enterprise team to triple its earnings from bio-based products and managing relationships with large institutional customers. His prior roles at Cargill included Business Development Director for Starches and Sweeteners North America as well as serving as an investment team member with the Emerging Business Accelerator, a group structured along corporate venture capital groups, to invest in white space opportunities for Cargill; he also worked in the Corporate Strategy & Development Group.
Over the years, Manoj has also served on the boards of both Calysta Inc. and Rivertop Renewables as a Cargill representative. He was responsible for leading Cargill’s equity investments in the industrial biotechnology space including co-investment in real assets with institutional financial investors to build a $600 million commercial-scale aquaculture nutrition plant. He also serves on Industry Advisory Board of Larta Institute which assists the USDA, NIH and NSF with the commercialization assistance program.
Manoj has lived and worked in South East Asia, Middle East, Europe and Americas. He enjoys sea kayaking, skiing, classical music and flying kites in his pastime.

Glenn Bowers - Vice President of Breeding

Glenn Bowers – Vice President of Breeding

Glenn Bowers is Vice President of Breeding with responsibilities for breeding, field trialing and seed production for all crops. Glenn has a M.S. and Ph.D. degree in Plant Pathology with a focus on breeding and genetics of resistance. He spent 17 years managing a soybean breeding program with Texas A&M University, followed by a year doing the same at Purdue University. He then spent 16 years with Syngenta, first managing a soybean breeding program and then as global head of soybean breeding. He has extensive experience in Argentina and Brazil, in addition to North America. Glenn is also a certified project manager (PMP).
Extensive experience in delivering products, both global and stateside, through effective collaboration with marketing and supply chain. Skilled in creating, developing, and managing diverse and globally dispersed teams. Deep knowledge of and experience in field trialing, disease phenotyping, and agronomy.

Jeremy Forest - Head of Legal

Jeremy Forest – Head of Legal

Jeremy joined Calyxt in September 2016 as Head of Legal, and manages the company’s day-to-day legal operations. Jeremy received his J.D. from the University of New Hampshire, where his studies included a concentration in intellectual property law. He also holds an M.S. in organic chemistry from the University of Hawaii and a B.A. in biochemistry from St. Anselm College. Prior to joining Calyxt, Jeremy served as General Counsel & Corporate Secretary of Biosynthetic Technologies, an early-stage biotechnology company based in Southern California. While at Biosynthetic, he built and managed a portfolio of more than 100 pending and issued patents, and devised and implemented an international patent program focused on the strategic procurement of offensive and defensive intellectual assets. He also has extensive experience negotiating and structuring corporate transactions related to joint development partnerships, technology licensing, and venture-backed investments. Jeremy started his career at Finnegan LLP in Silicon Valley, where his practice focused on client counseling in the areas of biotechnology and pharmaceuticals. He currently serves on the board of directors for a national non-profit organization.